FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304140863> ?p ?o ?g. }

• W4304140863 endingPage "e0770" @default.
• W4304140863 startingPage "e0770" @default.
• W4304140863 abstract "Although venovenous extracorporeal membrane oxygenation (VV ECMO) has been used in case of COVID-19 induced acute respiratory distress syndrome (ARDS), outcomes and criteria for its application should be evaluated.To describe patient characteristics and outcomes in patients receiving VV ECMO due to COVID-19-induced ARDS and to assess the possible impact of COVID-19 on mortality.Multicenter retrospective study in 15 ICUs worldwide. All adult patients (> 18 yr) were included if they received VV ECMO with ARDS as main indication. Two groups were created: a COVID-19 cohort from March 2020 to December 2020 and a control non-COVID ARDS cohort from January 2018 to July 2019.Collected data consisted of patient demographics, baseline variables, ECMO characteristics, and patient outcomes. The primary outcome was 60-day mortality. Secondary outcomes included patient characteristics, COVID-19-related therapies before and during ECMO and complication rate. To assess the influence of COVID-19 on mortality, inverse probability weighted (IPW) analyses were used to correct for predefined confounding variables.A total of 193 patients with COVID-19 received VV ECMO. The main indication for VV ECMO consisted of refractory hypoxemia, either isolated or combined with refractory hypercapnia. Complications with the highest occurrence rate included hemorrhage, an additional infectious event or acute kidney injury. Mortality was 35% and 45% at 28 and 60 days, respectively. Those mortality rates did not differ between the first and second waves of COVID-19 in 2020. Furthermore, 60-day mortality was equal between patients with COVID-19 and non-COVID-19-associated ARDS receiving VV ECMO (hazard ratio 60-d mortality, 1.27; 95% CI, 0.82-1.98; p = 0.30).Mortality for patients with COVID-19 who received VV ECMO was similar to that reported in other COVID-19 cohorts, although no differences were found between the first and second waves regarding mortality. In addition, after IPW, mortality was independent of the etiology of ARDS." @default.
• W4304140863 created "2022-10-11" @default.
• W4304140863 creator A5002573999 @default.
• W4304140863 creator A5007984532 @default.
• W4304140863 creator A5010850499 @default.
• W4304140863 creator A5026440161 @default.
• W4304140863 creator A5030507372 @default.
• W4304140863 creator A5031193023 @default.
• W4304140863 creator A5049655478 @default.
• W4304140863 creator A5051171018 @default.
• W4304140863 creator A5054087192 @default.
• W4304140863 creator A5055291765 @default.
• W4304140863 creator A5057700687 @default.
• W4304140863 creator A5059830049 @default.
• W4304140863 creator A5062113941 @default.
• W4304140863 creator A5064898626 @default.
• W4304140863 creator A5070064502 @default.
• W4304140863 creator A5073171672 @default.
• W4304140863 creator A5074043516 @default.
• W4304140863 creator A5075653242 @default.
• W4304140863 creator A5077382066 @default.
• W4304140863 creator A5081630147 @default.
• W4304140863 creator A5083242273 @default.
• W4304140863 creator A5083633309 @default.
• W4304140863 creator A5086752339 @default.
• W4304140863 creator A5088181114 @default.
• W4304140863 creator A5091512327 @default.
• W4304140863 date "2022-10-01" @default.
• W4304140863 modified "2023-10-02" @default.
• W4304140863 title "Outcomes of Extracorporeal Membrane Oxygenation in COVID-19–Induced Acute Respiratory Distress Syndrome: An Inverse Probability Weighted Analysis" @default.
• W4304140863 cites W2048608755 @default.
• W4304140863 cites W2125766343 @default.
• W4304140863 cites W2126049444 @default.
• W4304140863 cites W2576536258 @default.
• W4304140863 cites W2782802766 @default.
• W4304140863 cites W2803603947 @default.
• W4304140863 cites W2896849124 @default.
• W4304140863 cites W2967981766 @default.
• W4304140863 cites W3011061450 @default.
• W4304140863 cites W3012917182 @default.
• W4304140863 cites W3048382678 @default.
• W4304140863 cites W3049675062 @default.
• W4304140863 cites W3089328061 @default.
• W4304140863 cites W3134724323 @default.
• W4304140863 cites W3145060000 @default.
• W4304140863 cites W3155073785 @default.
• W4304140863 cites W3160191138 @default.
• W4304140863 cites W3169804878 @default.
• W4304140863 cites W3190672235 @default.
• W4304140863 cites W3197059639 @default.
• W4304140863 cites W3202915227 @default.
• W4304140863 cites W3205798050 @default.
• W4304140863 cites W3208119506 @default.
• W4304140863 cites W3212900021 @default.
• W4304140863 cites W3217086996 @default.
• W4304140863 cites W4206075507 @default.
• W4304140863 cites W4210642183 @default.
• W4304140863 cites W4213177646 @default.
• W4304140863 cites W4214814910 @default.
• W4304140863 doi "https://doi.org/10.1097/cce.0000000000000770" @default.
• W4304140863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36248318" @default.
• W4304140863 hasPublicationYear "2022" @default.
• W4304140863 type Work @default.
• W4304140863 citedByCount "2" @default.
• W4304140863 countsByYear W43041408632023 @default.
• W4304140863 crossrefType "journal-article" @default.
• W4304140863 hasAuthorship W4304140863A5002573999 @default.
• W4304140863 hasAuthorship W4304140863A5007984532 @default.
• W4304140863 hasAuthorship W4304140863A5010850499 @default.
• W4304140863 hasAuthorship W4304140863A5026440161 @default.
• W4304140863 hasAuthorship W4304140863A5030507372 @default.
• W4304140863 hasAuthorship W4304140863A5031193023 @default.
• W4304140863 hasAuthorship W4304140863A5049655478 @default.
• W4304140863 hasAuthorship W4304140863A5051171018 @default.
• W4304140863 hasAuthorship W4304140863A5054087192 @default.
• W4304140863 hasAuthorship W4304140863A5055291765 @default.
• W4304140863 hasAuthorship W4304140863A5057700687 @default.
• W4304140863 hasAuthorship W4304140863A5059830049 @default.
• W4304140863 hasAuthorship W4304140863A5062113941 @default.
• W4304140863 hasAuthorship W4304140863A5064898626 @default.
• W4304140863 hasAuthorship W4304140863A5070064502 @default.
• W4304140863 hasAuthorship W4304140863A5073171672 @default.
• W4304140863 hasAuthorship W4304140863A5074043516 @default.
• W4304140863 hasAuthorship W4304140863A5075653242 @default.
• W4304140863 hasAuthorship W4304140863A5077382066 @default.
• W4304140863 hasAuthorship W4304140863A5081630147 @default.
• W4304140863 hasAuthorship W4304140863A5083242273 @default.
• W4304140863 hasAuthorship W4304140863A5083633309 @default.
• W4304140863 hasAuthorship W4304140863A5086752339 @default.
• W4304140863 hasAuthorship W4304140863A5088181114 @default.
• W4304140863 hasAuthorship W4304140863A5091512327 @default.
• W4304140863 hasBestOaLocation W43041408631 @default.
• W4304140863 hasConcept C126322002 @default.
• W4304140863 hasConcept C167135981 @default.
• W4304140863 hasConcept C177713679 @default.
• W4304140863 hasConcept C179755657 @default.
• W4304140863 hasConcept C194828623 @default.
• W4304140863 hasConcept C2776348555 @default.

• next